A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

An estimated 50% of patients with SLE will develop lupus nephritis in their lifetime, with people of African descent more ...

The urinary albumin-creatinine ratio (UACR) is more strongly associated with kidney failure than the urinary ...

Compared with eGFRcr, a 30% lower eGFRcys was associated with higher rates of all-cause mortality, cardiovascular events, and kidney disease.

To address knowledge gaps, investigators conducted a meta-analysis of more than 70,000 patients in 10 trials of SGLT2 inhibitors vs placebo to determine the relative risks of CKD progression across ...

The phase 2 EXPLORE-CKD trial is examining the efficacy and safety of lorundrostat in addition to SGLT2 inhibitors in patients with hypertension and CKD with albuminuria.

A new tool can predict individualized probability of survival with conservative management (CM) versus dialysis transition ...

Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from ...

Balcinrenone is similar to finerenone (Kerendia), which is also a nonsteroidal MRA and was approved for the slowing of ...

Intensive blood pressure lowering yielded significant net benefits among patients with chronic kidney disease.

Full results from the Phase 2 REGEN-007 study of rilparencel were recently presented as a late-breaking clinical trial at the American Society of Nephrology (ASN) Kidney Week 2025More than half of the ...